4 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... events TZDs DPP ... Improved outcomes in CKD ... #medications #table
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
kidney disease, DPP4i ... —4 inhibitor, eGFR ... sulfonylurea; T2D. type 2 diabetes ... type 2 diabetes; ... #Diabetes Management
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology Summary ... Action: Inhibits DPP ... #Pharmacology #Summary ... #DM2 #diabetes